Attachment 3 Pricing_Chemistry.xlsx
XLSX spreadsheet 33 KB Posted
- Attached to
- Chemistry Analyzer and Reagents Keesler AFB
- Solicitation number
- HT940825R0008
- Issued by
-
Defense Health Agency
About this file
This is a comprehensive pricing attachment (Attachment 3) for a Chemistry Lab Analyzer and Reagent contract for Keesler Air Force Base Medical Center. The document details a five-year pricing structure covering base year and four option years from October 2025 to September 2030, with two Contract Line Item Numbers (CLINs): one for chemistry services and another for equipment delivery and installation.
The pricing worksheet includes an extensive list of chemistry tests across multiple categories including General Chemistry, Electrolytes, Immunochemistry, Urine Drugs of Abuse, Immunology, Therapeutic Drugs, Tumor Markers, Urine Chemistry, and Cardiac Tests. Each test category lists specific tests with annual quantities, though the current document shows $0 for unit and total prices. The contract is for the Defense Health Agency and is associated with Solicitation Number HT940825R0008, which seeks to provide chemistry analyzers, immunoassay analyzers, and an automated specimen track system with maintenance services, supplies, and reagents for the Department of Clinical Laboratory and Pathology Services at Keesler Air Force Base Medical Center in Mississippi.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| HT940825R0008 0002.pdf | ||
| HT940825R0008 0001.pdf | ||
| Attachment 2_CyberLOG MDERA.pdf | ||
| Attachment 1 HT940825R0008.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Base Year
| Chemistry Lab Analyzer and Reagent |
| Attachment 3 Pricing Worksheet |
| (BASE YEAR ) PoP: 01 October 2025 - 30 September 2026 | ||||
| CLIN | Description | Annual Quantity | Unit Price | Total |
| 0001 | Chemistry (equipment, maintenance, supplies/reagents) CPRR and Training |
Reference SOO paragraph 2, 3 and 4 PoP: 01 October 2025 - 30 September 2026
| GENERAL CHEMISTRY | ||||
| ALANINE AMINOTRANSFERASE (ALT) | 17,498 | $ - 0 | $ - 0 | |
| ALBUMIN | 36,205 | $ - 0 | $ - 0 | |
| ALKALINE PHOSPHATASE (ALP) | 16,972 | $ - 0 | $ - 0 | |
| AMMONIA | 117 | $ - 0 | $ - 0 | |
| AMYLASE | 222 | $ - 0 | $ - 0 | |
| ASPARTATE AMINOTRANSFERASE (AST) | 17,693 | $ - 0 | $ - 0 | |
| BLOOD UREA NITOGEN | 34,060 | $ - 0 | $ - 0 | |
| CALCIUM | 33,793 | $ - 0 | $ - 0 | |
| CARBON DIOXIDE | 33,513 | $ - 0 | $ - 0 | |
| CHOLESTEROL | 8,994 | $ - 0 | $ - 0 | |
| C-REACTIVE PROTIEN | 1,817 | $ - 0 | $ - 0 | |
| CREATINE KINASE - TOTAL | 536 | $ - 0 | $ - 0 | |
| CREATININE | 44,130 | $ - 0 | $ - 0 | |
| DIRECT BILIRUBIN | 2,917 | $ - 0 | $ - 0 | |
| ETHANOL (ETOH) | 451 | $ - 0 | $ - 0 | |
| GAMMA-GLUTAMYL TRANSFERASE | 328 | $ - 0 | $ - 0 | |
| GLUCOSE | 34,928 | $ - 0 | $ - 0 | |
| GLYCOCYLATED HEMAGLOBIN A1C | 10,754 | $ - 0 | $ - 0 | |
| HIGH DENSITY LYPOPROTIEN - DIRECT | 8,978 | $ - 0 | $ - 0 | |
| IRON (NO PRETREATMENT) | 5,370 | $ - 0 | $ - 0 | |
| LACTATE | 1,702 | $ - 0 | $ - 0 | |
| LACTIC DEHYDROGENASE | 697 | $ - 0 | $ - 0 | |
| LIPASE | 2,420 | $ - 0 | $ - 0 | |
| LOW DENSITY LYPOPROTIEN - DIRECT | 8,982 | $ - 0 | $ - 0 | |
| MAGNESIUM | 10,568 | $ - 0 | $ - 0 | |
| PHOSPHOROUS | 15,468 | $ - 0 | $ - 0 | |
| PREALBUMIN | 103 | $ - 0 | $ - 0 | |
| TOTAL BILIRUBIN | 17,367 | $ - 0 | $ - 0 | |
| TOTAL PROTEIN | 17,029 | $ - 0 | $ - 0 | |
| TOTAL/ UNSATURATED IRON BINDING CAPACITY | 5,376 | $ - 0 | $ - 0 | |
| TRANSFERRIN | 5,307 | $ - 0 | $ - 0 | |
| TRIGLYCERIDE | 9,044 | $ - 0 | $ - 0 | |
| URIC ACID | 1,433 | $ - 0 | $ - 0 | |
| ELECTROLYTES | ||||
| CHLORIDE | 39,084 | $ - 0 | $ - 0 | |
| POTASSIUM | 39,084 | $ - 0 | $ - 0 | |
| SODIUM | 39,084 | $ - 0 | $ - 0 | |
| IMMUNOCHEMISTRY | ||||
| 25-OH, VITAMIN D | 6,948 | $ - 0 | $ - 0 | |
| 3RD GENERATION THYROID STYMULATING HORMONE (TSH) | 8,623 | $ - 0 | $ - 0 | |
| B12, VITAMIN | 3,081 | $ - 0 | $ - 0 | |
| Beta HUMAN CHORIONIC GONADOTROPIN (Beta- HCG) | 998 | $ - 0 | $ - 0 | |
| CORTISOL | 267 | $ - 0 | $ - 0 | |
| ESTRADIOL | 299 | $ - 0 | $ - 0 | |
| FERRITIN | 3,674 | $ - 0 | $ - 0 | |
| FOLATE | 3,081 | $ - 0 | $ - 0 | |
| FOLLICLE STIMULATING HORMONE (FSH) | 489 | $ - 0 | $ - 0 | |
| FREE THYROXINE (FT4) | 4,030 | $ - 0 | $ - 0 | |
| INSULIN | 158 | $ - 0 | $ - 0 | |
| LUTEINIZING HORMONE (LH) | 489 | $ - 0 | $ - 0 | |
| PROCALCITONIN | 263 | $ - 0 | $ - 0 | |
| PROGESTERONE | 138 | $ - 0 | $ - 0 | |
| PROLACTIN | 860 | $ - 0 | $ - 0 | |
| RAPID/INTACT PARATHYROID HORMONE (PTH) THAT IS INTRAOPERATIVE CAPABLE | 2,041 | $ - 0 | $ - 0 | |
| TOTAL TESTOSTERONE | 433 | $ - 0 | $ - 0 | |
| TRIIODOTHYRONINE (FREE T3) | 312 | $ - 0 | $ - 0 | |
| URINE DRUGS OF ABUSE | $ - 0 | $ - 0 | ||
| AMPHETAMINE | 1,028 | $ - 0 | $ - 0 | |
| BARBITURATE | 1,028 | $ - 0 | $ - 0 | |
| BENZODIAZEPINE | 1,028 | $ - 0 | $ - 0 | |
| CANNOBINOID | 1,028 | $ - 0 | $ - 0 | |
| COCAINE | 1,028 | $ - 0 | $ - 0 | |
| OPIATE | 1,028 | $ - 0 | $ - 0 | |
| PHENCYCLIDINE | 1,028 | $ - 0 | $ - 0 | |
| IMMUNONOLOGY | ||||
| ANTI STREPTOLYSIN O (ASO) | 27 | $ - 0 | $ - 0 | |
| IMMUNOGLOBULIN A | 262 | $ - 0 | $ - 0 | |
| IMMUNOGLOBULIN G | 227 | $ - 0 | $ - 0 | |
| IMMUNOGLOBULIN M | 227 | $ - 0 | $ - 0 | |
| RHEUMATOID FACTOR (RF) | 378 | $ - 0 | $ - 0 | |
| THERAPEUTIC DRUGS | ||||
| ACETAMINOPHEN | 297 | $ - 0 | $ - 0 | |
| CARBAMAZEPINE | 30 | $ - 0 | $ - 0 | |
| DIGOXIN | 59 | $ - 0 | $ - 0 | |
| GENTAMICIN | 24 | $ - 0 | $ - 0 | |
| LITHIUM | 50 | $ - 0 | $ - 0 | |
| PHENOBARBITAL | 31 | $ - 0 | $ - 0 | |
| PHENYTOIN | 27 | $ - 0 | $ - 0 | |
| SALICYLATE | 254 | $ - 0 | $ - 0 | |
| TOBRAMYCIN | 21 | $ - 0 | $ - 0 | |
| THEOPHYLLINE | 23 | $ - 0 | $ - 0 | |
| VALPORIC ACID | 62 | $ - 0 | $ - 0 | |
| VANCOMYCIN | 250 | $ - 0 | $ - 0 | |
| Tumor Markers | ||||
| 3RD GENERATION TOTAL PROSTATE SPECIFIC ANTIGEN (PSA) | 2,576 | $ - 0 | $ - 0 | |
| ALPHA FETAL PROTIEN | 212 | $ - 0 | $ - 0 | |
| CA-125 ANTIGEN | 95 | $ - 0 | $ - 0 | |
| CARCINOEMBRYONIC ANTIGEN (CEA) | 231 | $ - 0 | $ - 0 | |
| FREE PROSTATE SPECIFIC ANTIGEN (PSA) | 458 | $ - 0 | $ - 0 | |
| URINE CHEMISTRY | ||||
| MICROALBUMIN | 8,119 | $ - 0 | $ - 0 | |
| URINE TOTAL PROTEIN/ CSF TOTAL PROTEIN | 2,103 | $ - 0 | $ - 0 | |
| CARDIAC TESTS | ||||
| CREATINE KINASE - MUSCLE BRAIN | 84 | $ - 0 | $ - 0 | |
| HIGH SENSITIVEITY TROPONIN I | 4,936 | $ - 0 | $ - 0 | |
| HIGH SENSITIVITY C-REACTIVE PROTIEN | 135 | $ - 0 | $ - 0 | |
| N TERMINAL-PRO BRAIN NATRIURETIC PEPTIDE | 2,244 | $ - 0 | $ - 0 | |
| CLIN 0001 TOTAL | $ - 0 | |||
| 0002 | Equipment Delivery, Install and Validation | 1 | $ - 0 | $ - 0 |
| CLIN 0002 TOTAL | $ - 0 |
TOTAL (Including all options) $ - 0
Option Year 1
| Chemistry Lab Analyzer and Reagent |
| Attachment 3 Pricing Worksheet |
| (OPTION YEAR 1 ) PoP: 01 October 2026 - 30 September 2027 | ||||
| CLIN | Description | Annual Quantity | Unit Price | Total |
| 1001 | Chemistry (equipment, maintenance, supplies/reagents) CPRR and Training |
Reference SOO paragraph 2, 3 and 4 PoP: 01 October 2026 - 30 September 2027
| GENERAL CHEMISTRY | |||
| ALANINE AMINOTRANSFERASE (ALT) | 17,498 | $ - 0 | $ - 0 |
| ALBUMIN | 36,205 | $ - 0 | $ - 0 |
| ALKALINE PHOSPHATASE (ALP) | 16,972 | $ - 0 | $ - 0 |
| AMMONIA | 117 | $ - 0 | $ - 0 |
| AMYLASE | 222 | $ - 0 | $ - 0 |
| ASPARTATE AMINOTRANSFERASE (AST) | 17,693 | $ - 0 | $ - 0 |
| BLOOD UREA NITOGEN | 34,060 | $ - 0 | $ - 0 |
| CALCIUM | 33,793 | $ - 0 | $ - 0 |
| CARBON DIOXIDE | 33,513 | $ - 0 | $ - 0 |
| CHOLESTEROL | 8,994 | $ - 0 | $ - 0 |
| C-REACTIVE PROTIEN | 1,817 | $ - 0 | $ - 0 |
| CREATINE KINASE - TOTAL | 536 | $ - 0 | $ - 0 |
| CREATININE | 44,130 | $ - 0 | $ - 0 |
| DIRECT BILIRUBIN | 2,917 | $ - 0 | $ - 0 |
| ETHANOL (ETOH) | 451 | $ - 0 | $ - 0 |
| GAMMA-GLUTAMYL TRANSFERASE | 328 | $ - 0 | $ - 0 |
| GLUCOSE | 34,928 | $ - 0 | $ - 0 |
| GLYCOCYLATED HEMAGLOBIN A1C | 10,754 | $ - 0 | $ - 0 |
| HIGH DENSITY LYPOPROTIEN - DIRECT | 8,978 | $ - 0 | $ - 0 |
| IRON (NO PRETREATMENT) | 5,370 | $ - 0 | $ - 0 |
| LACTATE | 1,702 | $ - 0 | $ - 0 |
| LACTIC DEHYDROGENASE | 697 | $ - 0 | $ - 0 |
| LIPASE | 2,420 | $ - 0 | $ - 0 |
| LOW DENSITY LYPOPROTIEN - DIRECT | 8,982 | $ - 0 | $ - 0 |
| MAGNESIUM | 10,568 | $ - 0 | $ - 0 |
| PHOSPHOROUS | 15,468 | $ - 0 | $ - 0 |
| PREALBUMIN | 103 | $ - 0 | $ - 0 |
| TOTAL BILIRUBIN | 17,367 | $ - 0 | $ - 0 |
| TOTAL PROTEIN | 17,029 | $ - 0 | $ - 0 |
| TOTAL/ UNSATURATED IRON BINDING CAPACITY | 5,376 | $ - 0 | $ - 0 |
| TRANSFERRIN | 5,307 | $ - 0 | $ - 0 |
| TRIGLYCERIDE | 9,044 | $ - 0 | $ - 0 |
| URIC ACID | 1,433 | $ - 0 | $ - 0 |
| ELECTROLYTES | |||
| CHLORIDE | 39,084 | $ - 0 | $ - 0 |
| POTASSIUM | 39,084 | $ - 0 | $ - 0 |
| SODIUM | 39,084 | $ - 0 | $ - 0 |
| IMMUNOCHEMISTRY | |||
| 25-OH, VITAMIN D | 6,948 | $ - 0 | $ - 0 |
| 3RD GENERATION THYROID STYMULATING HORMONE (TSH) | 8,623 | $ - 0 | $ - 0 |
| B12, VITAMIN | 3,081 | $ - 0 | $ - 0 |
| Beta HUMAN CHORIONIC GONADOTROPIN (Beta- HCG) | 998 | $ - 0 | $ - 0 |
| CORTISOL | 267 | $ - 0 | $ - 0 |
| ESTRADIOL | 299 | $ - 0 | $ - 0 |
| FERRITIN | 3,674 | $ - 0 | $ - 0 |
| FOLATE | 3,081 | $ - 0 | $ - 0 |
| FOLLICLE STIMULATING HORMONE (FSH) | 489 | $ - 0 | $ - 0 |
| FREE THYROXINE (FT4) | 4,030 | $ - 0 | $ - 0 |
| INSULIN | 158 | $ - 0 | $ - 0 |
| LUTEINIZING HORMONE (LH) | 489 | $ - 0 | $ - 0 |
| PROCALCITONIN | 263 | $ - 0 | $ - 0 |
| PROGESTERONE | 138 | $ - 0 | $ - 0 |
| PROLACTIN | 860 | $ - 0 | $ - 0 |
| RAPID/INTACT PARATHYROID HORMONE (PTH) THAT IS INTRAOPERATIVE CAPABLE | 2,041 | $ - 0 | $ - 0 |
| TOTAL TESTOSTERONE | 433 | $ - 0 | $ - 0 |
| TRIIODOTHYRONINE (FREE T3) | 312 | $ - 0 | $ - 0 |
| URINE DRUGS OF ABUSE | $ - 0 | $ - 0 | |
| AMPHETAMINE | 1,028 | $ - 0 | $ - 0 |
| BARBITURATE | 1,028 | $ - 0 | $ - 0 |
| BENZODIAZEPINE | 1,028 | $ - 0 | $ - 0 |
| CANNOBINOID | 1,028 | $ - 0 | $ - 0 |
| COCAINE | 1,028 | $ - 0 | $ - 0 |
| OPIATE | 1,028 | $ - 0 | $ - 0 |
| PHENCYCLIDINE | 1,028 | $ - 0 | $ - 0 |
| IMMUNONOLOGY | |||
| ANTI STREPTOLYSIN O (ASO) | 27 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN A | 262 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN G | 227 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN M | 227 | $ - 0 | $ - 0 |
| RHEUMATOID FACTOR (RF) | 378 | $ - 0 | $ - 0 |
| THERAPEUTIC DRUGS | |||
| ACETAMINOPHEN | 297 | $ - 0 | $ - 0 |
| CARBAMAZEPINE | 30 | $ - 0 | $ - 0 |
| DIGOXIN | 59 | $ - 0 | $ - 0 |
| GENTAMICIN | 24 | $ - 0 | $ - 0 |
| LITHIUM | 50 | $ - 0 | $ - 0 |
| PHENOBARBITAL | 31 | $ - 0 | $ - 0 |
| PHENYTOIN | 27 | $ - 0 | $ - 0 |
| SALICYLATE | 254 | $ - 0 | $ - 0 |
| TOBRAMYCIN | 21 | $ - 0 | $ - 0 |
| THEOPHYLLINE | 23 | $ - 0 | $ - 0 |
| VALPORIC ACID | 62 | $ - 0 | $ - 0 |
| VANCOMYCIN | 250 | $ - 0 | $ - 0 |
| Tumor Markers | |||
| 3RD GENERATION TOTAL PROSTATE SPECIFIC ANTIGEN (PSA) | 2,576 | $ - 0 | $ - 0 |
| ALPHA FETAL PROTIEN | 212 | $ - 0 | $ - 0 |
| CA-125 ANTIGEN | 95 | $ - 0 | $ - 0 |
| CARCINOEMBRYONIC ANTIGEN (CEA) | 231 | $ - 0 | $ - 0 |
| FREE PROSTATE SPECIFIC ANTIGEN (PSA) | 458 | $ - 0 | $ - 0 |
| URINE CHEMISTRY | |||
| MICROALBUMIN | 8,119 | $ - 0 | $ - 0 |
| URINE TOTAL PROTEIN/ CSF TOTAL PROTEIN | 2,103 | $ - 0 | $ - 0 |
| CARDIAC TESTS | |||
| CREATINE KINASE - MUSCLE BRAIN | 84 | $ - 0 | $ - 0 |
| HIGH SENSITIVEITY TROPONIN I | 4,936 | $ - 0 | $ - 0 |
| HIGH SENSITIVITY C-REACTIVE PROTIEN | 135 | $ - 0 | $ - 0 |
| N TERMINAL-PRO BRAIN NATRIURETIC PEPTIDE | 2,244 | $ - 0 | $ - 0 |
| CLIN 1001 TOTAL | $ - 0 |
Option Year 2
| Chemistry Lab Analyzer and Reagent |
| Attachment 3 Pricing Worksheet |
| (OPTION YEAR 2 ) PoP: 01 October 2027 - 30 September 2028 | ||||
| CLIN | Description | Annual Quantity | Unit Price | Total |
| 2001 | Chemistry (equipment, maintenance, supplies/reagents) CPRR and Training |
Reference SOO paragraph 2, 3 and 4 PoP: 01 October 2027 - 30 September 2028
| GENERAL CHEMISTRY | |||
| ALANINE AMINOTRANSFERASE (ALT) | 17,498 | $ - 0 | $ - 0 |
| ALBUMIN | 36,205 | $ - 0 | $ - 0 |
| ALKALINE PHOSPHATASE (ALP) | 16,972 | $ - 0 | $ - 0 |
| AMMONIA | 117 | $ - 0 | $ - 0 |
| AMYLASE | 222 | $ - 0 | $ - 0 |
| ASPARTATE AMINOTRANSFERASE (AST) | 17,693 | $ - 0 | $ - 0 |
| BLOOD UREA NITOGEN | 34,060 | $ - 0 | $ - 0 |
| CALCIUM | 33,793 | $ - 0 | $ - 0 |
| CARBON DIOXIDE | 33,513 | $ - 0 | $ - 0 |
| CHOLESTEROL | 8,994 | $ - 0 | $ - 0 |
| C-REACTIVE PROTIEN | 1,817 | $ - 0 | $ - 0 |
| CREATINE KINASE - TOTAL | 536 | $ - 0 | $ - 0 |
| CREATININE | 44,130 | $ - 0 | $ - 0 |
| DIRECT BILIRUBIN | 2,917 | $ - 0 | $ - 0 |
| ETHANOL (ETOH) | 451 | $ - 0 | $ - 0 |
| GAMMA-GLUTAMYL TRANSFERASE | 328 | $ - 0 | $ - 0 |
| GLUCOSE | 34,928 | $ - 0 | $ - 0 |
| GLYCOCYLATED HEMAGLOBIN A1C | 10,754 | $ - 0 | $ - 0 |
| HIGH DENSITY LYPOPROTIEN - DIRECT | 8,978 | $ - 0 | $ - 0 |
| IRON (NO PRETREATMENT) | 5,370 | $ - 0 | $ - 0 |
| LACTATE | 1,702 | $ - 0 | $ - 0 |
| LACTIC DEHYDROGENASE | 697 | $ - 0 | $ - 0 |
| LIPASE | 2,420 | $ - 0 | $ - 0 |
| LOW DENSITY LYPOPROTIEN - DIRECT | 8,982 | $ - 0 | $ - 0 |
| MAGNESIUM | 10,568 | $ - 0 | $ - 0 |
| PHOSPHOROUS | 15,468 | $ - 0 | $ - 0 |
| PREALBUMIN | 103 | $ - 0 | $ - 0 |
| TOTAL BILIRUBIN | 17,367 | $ - 0 | $ - 0 |
| TOTAL PROTEIN | 17,029 | $ - 0 | $ - 0 |
| TOTAL/ UNSATURATED IRON BINDING CAPACITY | 5,376 | $ - 0 | $ - 0 |
| TRANSFERRIN | 5,307 | $ - 0 | $ - 0 |
| TRIGLYCERIDE | 9,044 | $ - 0 | $ - 0 |
| URIC ACID | 1,433 | $ - 0 | $ - 0 |
| ELECTROLYTES | |||
| CHLORIDE | 39,084 | $ - 0 | $ - 0 |
| POTASSIUM | 39,084 | $ - 0 | $ - 0 |
| SODIUM | 39,084 | $ - 0 | $ - 0 |
| IMMUNOCHEMISTRY | |||
| 25-OH, VITAMIN D | 6,948 | $ - 0 | $ - 0 |
| 3RD GENERATION THYROID STYMULATING HORMONE (TSH) | 8,623 | $ - 0 | $ - 0 |
| B12, VITAMIN | 3,081 | $ - 0 | $ - 0 |
| Beta HUMAN CHORIONIC GONADOTROPIN (Beta- HCG) | 998 | $ - 0 | $ - 0 |
| CORTISOL | 267 | $ - 0 | $ - 0 |
| ESTRADIOL | 299 | $ - 0 | $ - 0 |
| FERRITIN | 3,674 | $ - 0 | $ - 0 |
| FOLATE | 3,081 | $ - 0 | $ - 0 |
| FOLLICLE STIMULATING HORMONE (FSH) | 489 | $ - 0 | $ - 0 |
| FREE THYROXINE (FT4) | 4,030 | $ - 0 | $ - 0 |
| INSULIN | 158 | $ - 0 | $ - 0 |
| LUTEINIZING HORMONE (LH) | 489 | $ - 0 | $ - 0 |
| PROCALCITONIN | 263 | $ - 0 | $ - 0 |
| PROGESTERONE | 138 | $ - 0 | $ - 0 |
| PROLACTIN | 860 | $ - 0 | $ - 0 |
| RAPID/INTACT PARATHYROID HORMONE (PTH) THAT IS INTRAOPERATIVE CAPABLE | 2,041 | $ - 0 | $ - 0 |
| TOTAL TESTOSTERONE | 433 | $ - 0 | $ - 0 |
| TRIIODOTHYRONINE (FREE T3) | 312 | $ - 0 | $ - 0 |
| URINE DRUGS OF ABUSE | $ - 0 | $ - 0 | |
| AMPHETAMINE | 1,028 | $ - 0 | $ - 0 |
| BARBITURATE | 1,028 | $ - 0 | $ - 0 |
| BENZODIAZEPINE | 1,028 | $ - 0 | $ - 0 |
| CANNOBINOID | 1,028 | $ - 0 | $ - 0 |
| COCAINE | 1,028 | $ - 0 | $ - 0 |
| OPIATE | 1,028 | $ - 0 | $ - 0 |
| PHENCYCLIDINE | 1,028 | $ - 0 | $ - 0 |
| IMMUNONOLOGY | |||
| ANTI STREPTOLYSIN O (ASO) | 27 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN A | 262 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN G | 227 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN M | 227 | $ - 0 | $ - 0 |
| RHEUMATOID FACTOR (RF) | 378 | $ - 0 | $ - 0 |
| THERAPEUTIC DRUGS | |||
| ACETAMINOPHEN | 297 | $ - 0 | $ - 0 |
| CARBAMAZEPINE | 30 | $ - 0 | $ - 0 |
| DIGOXIN | 59 | $ - 0 | $ - 0 |
| GENTAMICIN | 24 | $ - 0 | $ - 0 |
| LITHIUM | 50 | $ - 0 | $ - 0 |
| PHENOBARBITAL | 31 | $ - 0 | $ - 0 |
| PHENYTOIN | 27 | $ - 0 | $ - 0 |
| SALICYLATE | 254 | $ - 0 | $ - 0 |
| TOBRAMYCIN | 21 | $ - 0 | $ - 0 |
| THEOPHYLLINE | 23 | $ - 0 | $ - 0 |
| VALPORIC ACID | 62 | $ - 0 | $ - 0 |
| VANCOMYCIN | 250 | $ - 0 | $ - 0 |
| Tumor Markers | |||
| 3RD GENERATION TOTAL PROSTATE SPECIFIC ANTIGEN (PSA) | 2,576 | $ - 0 | $ - 0 |
| ALPHA FETAL PROTIEN | 212 | $ - 0 | $ - 0 |
| CA-125 ANTIGEN | 95 | $ - 0 | $ - 0 |
| CARCINOEMBRYONIC ANTIGEN (CEA) | 231 | $ - 0 | $ - 0 |
| FREE PROSTATE SPECIFIC ANTIGEN (PSA) | 458 | $ - 0 | $ - 0 |
| URINE CHEMISTRY | |||
| MICROALBUMIN | 8,119 | $ - 0 | $ - 0 |
| URINE TOTAL PROTEIN/ CSF TOTAL PROTEIN | 2,103 | $ - 0 | $ - 0 |
| CARDIAC TESTS | |||
| CREATINE KINASE - MUSCLE BRAIN | 84 | $ - 0 | $ - 0 |
| HIGH SENSITIVEITY TROPONIN I | 4,936 | $ - 0 | $ - 0 |
| HIGH SENSITIVITY C-REACTIVE PROTIEN | 135 | $ - 0 | $ - 0 |
| N TERMINAL-PRO BRAIN NATRIURETIC PEPTIDE | 2,244 | $ - 0 | $ - 0 |
| CLIN 2001 TOTAL | $ - 0 |
Option Year 3
| Chemistry Lab Analyzer and Reagent |
| Attachment 3 Pricing Worksheet |
| (OPTION YEAR 3 ) PoP: 01 October 2028 - 30 September 2029 | ||||
| CLIN | Description | Annual Quantity | Unit Price | Total |
| 3001 | Chemistry (equipment, maintenance, supplies/reagents) CPRR and Training |
Reference SOO paragraph 2, 3 and 4 PoP: 01 October 2028 - 30 September 2029
| GENERAL CHEMISTRY | |||
| ALANINE AMINOTRANSFERASE (ALT) | 17,498 | $ - 0 | $ - 0 |
| ALBUMIN | 36,205 | $ - 0 | $ - 0 |
| ALKALINE PHOSPHATASE (ALP) | 16,972 | $ - 0 | $ - 0 |
| AMMONIA | 117 | $ - 0 | $ - 0 |
| AMYLASE | 222 | $ - 0 | $ - 0 |
| ASPARTATE AMINOTRANSFERASE (AST) | 17,693 | $ - 0 | $ - 0 |
| BLOOD UREA NITOGEN | 34,060 | $ - 0 | $ - 0 |
| CALCIUM | 33,793 | $ - 0 | $ - 0 |
| CARBON DIOXIDE | 33,513 | $ - 0 | $ - 0 |
| CHOLESTEROL | 8,994 | $ - 0 | $ - 0 |
| C-REACTIVE PROTIEN | 1,817 | $ - 0 | $ - 0 |
| CREATINE KINASE - TOTAL | 536 | $ - 0 | $ - 0 |
| CREATININE | 44,130 | $ - 0 | $ - 0 |
| DIRECT BILIRUBIN | 2,917 | $ - 0 | $ - 0 |
| ETHANOL (ETOH) | 451 | $ - 0 | $ - 0 |
| GAMMA-GLUTAMYL TRANSFERASE | 328 | $ - 0 | $ - 0 |
| GLUCOSE | 34,928 | $ - 0 | $ - 0 |
| GLYCOCYLATED HEMAGLOBIN A1C | 10,754 | $ - 0 | $ - 0 |
| HIGH DENSITY LYPOPROTIEN - DIRECT | 8,978 | $ - 0 | $ - 0 |
| IRON (NO PRETREATMENT) | 5,370 | $ - 0 | $ - 0 |
| LACTATE | 1,702 | $ - 0 | $ - 0 |
| LACTIC DEHYDROGENASE | 697 | $ - 0 | $ - 0 |
| LIPASE | 2,420 | $ - 0 | $ - 0 |
| LOW DENSITY LYPOPROTIEN - DIRECT | 8,982 | $ - 0 | $ - 0 |
| MAGNESIUM | 10,568 | $ - 0 | $ - 0 |
| PHOSPHOROUS | 15,468 | $ - 0 | $ - 0 |
| PREALBUMIN | 103 | $ - 0 | $ - 0 |
| TOTAL BILIRUBIN | 17,367 | $ - 0 | $ - 0 |
| TOTAL PROTEIN | 17,029 | $ - 0 | $ - 0 |
| TOTAL/ UNSATURATED IRON BINDING CAPACITY | 5,376 | $ - 0 | $ - 0 |
| TRANSFERRIN | 5,307 | $ - 0 | $ - 0 |
| TRIGLYCERIDE | 9,044 | $ - 0 | $ - 0 |
| URIC ACID | 1,433 | $ - 0 | $ - 0 |
| ELECTROLYTES | |||
| CHLORIDE | 39,084 | $ - 0 | $ - 0 |
| POTASSIUM | 39,084 | $ - 0 | $ - 0 |
| SODIUM | 39,084 | $ - 0 | $ - 0 |
| IMMUNOCHEMISTRY | |||
| 25-OH, VITAMIN D | 6,948 | $ - 0 | $ - 0 |
| 3RD GENERATION THYROID STYMULATING HORMONE (TSH) | 8,623 | $ - 0 | $ - 0 |
| B12, VITAMIN | 3,081 | $ - 0 | $ - 0 |
| Beta HUMAN CHORIONIC GONADOTROPIN (Beta- HCG) | 998 | $ - 0 | $ - 0 |
| CORTISOL | 267 | $ - 0 | $ - 0 |
| ESTRADIOL | 299 | $ - 0 | $ - 0 |
| FERRITIN | 3,674 | $ - 0 | $ - 0 |
| FOLATE | 3,081 | $ - 0 | $ - 0 |
| FOLLICLE STIMULATING HORMONE (FSH) | 489 | $ - 0 | $ - 0 |
| FREE THYROXINE (FT4) | 4,030 | $ - 0 | $ - 0 |
| INSULIN | 158 | $ - 0 | $ - 0 |
| LUTEINIZING HORMONE (LH) | 489 | $ - 0 | $ - 0 |
| PROCALCITONIN | 263 | $ - 0 | $ - 0 |
| PROGESTERONE | 138 | $ - 0 | $ - 0 |
| PROLACTIN | 860 | $ - 0 | $ - 0 |
| RAPID/INTACT PARATHYROID HORMONE (PTH) THAT IS INTRAOPERATIVE CAPABLE | 2,041 | $ - 0 | $ - 0 |
| TOTAL TESTOSTERONE | 433 | $ - 0 | $ - 0 |
| TRIIODOTHYRONINE (FREE T3) | 312 | $ - 0 | $ - 0 |
| URINE DRUGS OF ABUSE | $ - 0 | $ - 0 | |
| AMPHETAMINE | 1,028 | $ - 0 | $ - 0 |
| BARBITURATE | 1,028 | $ - 0 | $ - 0 |
| BENZODIAZEPINE | 1,028 | $ - 0 | $ - 0 |
| CANNOBINOID | 1,028 | $ - 0 | $ - 0 |
| COCAINE | 1,028 | $ - 0 | $ - 0 |
| OPIATE | 1,028 | $ - 0 | $ - 0 |
| PHENCYCLIDINE | 1,028 | $ - 0 | $ - 0 |
| IMMUNONOLOGY | |||
| ANTI STREPTOLYSIN O (ASO) | 27 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN A | 262 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN G | 227 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN M | 227 | $ - 0 | $ - 0 |
| RHEUMATOID FACTOR (RF) | 378 | $ - 0 | $ - 0 |
| THERAPEUTIC DRUGS | |||
| ACETAMINOPHEN | 297 | $ - 0 | $ - 0 |
| CARBAMAZEPINE | 30 | $ - 0 | $ - 0 |
| DIGOXIN | 59 | $ - 0 | $ - 0 |
| GENTAMICIN | 24 | $ - 0 | $ - 0 |
| LITHIUM | 50 | $ - 0 | $ - 0 |
| PHENOBARBITAL | 31 | $ - 0 | $ - 0 |
| PHENYTOIN | 27 | $ - 0 | $ - 0 |
| SALICYLATE | 254 | $ - 0 | $ - 0 |
| TOBRAMYCIN | 21 | $ - 0 | $ - 0 |
| THEOPHYLLINE | 23 | $ - 0 | $ - 0 |
| VALPORIC ACID | 62 | $ - 0 | $ - 0 |
| VANCOMYCIN | 250 | $ - 0 | $ - 0 |
| Tumor Markers | |||
| 3RD GENERATION TOTAL PROSTATE SPECIFIC ANTIGEN (PSA) | 2,576 | $ - 0 | $ - 0 |
| ALPHA FETAL PROTIEN | 212 | $ - 0 | $ - 0 |
| CA-125 ANTIGEN | 95 | $ - 0 | $ - 0 |
| CARCINOEMBRYONIC ANTIGEN (CEA) | 231 | $ - 0 | $ - 0 |
| FREE PROSTATE SPECIFIC ANTIGEN (PSA) | 458 | $ - 0 | $ - 0 |
| URINE CHEMISTRY | |||
| MICROALBUMIN | 8,119 | $ - 0 | $ - 0 |
| URINE TOTAL PROTEIN/ CSF TOTAL PROTEIN | 2,103 | $ - 0 | $ - 0 |
| CARDIAC TESTS | |||
| CREATINE KINASE - MUSCLE BRAIN | 84 | $ - 0 | $ - 0 |
| HIGH SENSITIVEITY TROPONIN I | 4,936 | $ - 0 | $ - 0 |
| HIGH SENSITIVITY C-REACTIVE PROTIEN | 135 | $ - 0 | $ - 0 |
| N TERMINAL-PRO BRAIN NATRIURETIC PEPTIDE | 2,244 | $ - 0 | $ - 0 |
| CLIN 3001 TOTAL | $ - 0 |
Option Year 4
| Chemistry Lab Analyzer and Reagent |
| Attachment 3 Pricing Worksheet |
| (OPTION YEAR 4 ) PoP: 01 October 2029 - 30 September 2030 | ||||
| CLIN | Description | Annual Quantity | Unit Price | Total |
| 4001 | Chemistry (equipment, maintenance, supplies/reagents) CPRR and Training |
Reference SOO paragraph 2, 3 and 4 PoP: 01 October 2029 - 30 September 2030
| GENERAL CHEMISTRY | |||
| ALANINE AMINOTRANSFERASE (ALT) | 17,498 | $ - 0 | $ - 0 |
| ALBUMIN | 36,205 | $ - 0 | $ - 0 |
| ALKALINE PHOSPHATASE (ALP) | 16,972 | $ - 0 | $ - 0 |
| AMMONIA | 117 | $ - 0 | $ - 0 |
| AMYLASE | 222 | $ - 0 | $ - 0 |
| ASPARTATE AMINOTRANSFERASE (AST) | 17,693 | $ - 0 | $ - 0 |
| BLOOD UREA NITOGEN | 34,060 | $ - 0 | $ - 0 |
| CALCIUM | 33,793 | $ - 0 | $ - 0 |
| CARBON DIOXIDE | 33,513 | $ - 0 | $ - 0 |
| CHOLESTEROL | 8,994 | $ - 0 | $ - 0 |
| C-REACTIVE PROTIEN | 1,817 | $ - 0 | $ - 0 |
| CREATINE KINASE - TOTAL | 536 | $ - 0 | $ - 0 |
| CREATININE | 44,130 | $ - 0 | $ - 0 |
| DIRECT BILIRUBIN | 2,917 | $ - 0 | $ - 0 |
| ETHANOL (ETOH) | 451 | $ - 0 | $ - 0 |
| GAMMA-GLUTAMYL TRANSFERASE | 328 | $ - 0 | $ - 0 |
| GLUCOSE | 34,928 | $ - 0 | $ - 0 |
| GLYCOCYLATED HEMAGLOBIN A1C | 10,754 | $ - 0 | $ - 0 |
| HIGH DENSITY LYPOPROTIEN - DIRECT | 8,978 | $ - 0 | $ - 0 |
| IRON (NO PRETREATMENT) | 5,370 | $ - 0 | $ - 0 |
| LACTATE | 1,702 | $ - 0 | $ - 0 |
| LACTIC DEHYDROGENASE | 697 | $ - 0 | $ - 0 |
| LIPASE | 2,420 | $ - 0 | $ - 0 |
| LOW DENSITY LYPOPROTIEN - DIRECT | 8,982 | $ - 0 | $ - 0 |
| MAGNESIUM | 10,568 | $ - 0 | $ - 0 |
| PHOSPHOROUS | 15,468 | $ - 0 | $ - 0 |
| PREALBUMIN | 103 | $ - 0 | $ - 0 |
| TOTAL BILIRUBIN | 17,367 | $ - 0 | $ - 0 |
| TOTAL PROTEIN | 17,029 | $ - 0 | $ - 0 |
| TOTAL/ UNSATURATED IRON BINDING CAPACITY | 5,376 | $ - 0 | $ - 0 |
| TRANSFERRIN | 5,307 | $ - 0 | $ - 0 |
| TRIGLYCERIDE | 9,044 | $ - 0 | $ - 0 |
| URIC ACID | 1,433 | $ - 0 | $ - 0 |
| ELECTROLYTES | |||
| CHLORIDE | 39,084 | $ - 0 | $ - 0 |
| POTASSIUM | 39,084 | $ - 0 | $ - 0 |
| SODIUM | 39,084 | $ - 0 | $ - 0 |
| IMMUNOCHEMISTRY | |||
| 25-OH, VITAMIN D | 6,948 | $ - 0 | $ - 0 |
| 3RD GENERATION THYROID STYMULATING HORMONE (TSH) | 8,623 | $ - 0 | $ - 0 |
| B12, VITAMIN | 3,081 | $ - 0 | $ - 0 |
| Beta HUMAN CHORIONIC GONADOTROPIN (Beta- HCG) | 998 | $ - 0 | $ - 0 |
| CORTISOL | 267 | $ - 0 | $ - 0 |
| ESTRADIOL | 299 | $ - 0 | $ - 0 |
| FERRITIN | 3,674 | $ - 0 | $ - 0 |
| FOLATE | 3,081 | $ - 0 | $ - 0 |
| FOLLICLE STIMULATING HORMONE (FSH) | 489 | $ - 0 | $ - 0 |
| FREE THYROXINE (FT4) | 4,030 | $ - 0 | $ - 0 |
| INSULIN | 158 | $ - 0 | $ - 0 |
| LUTEINIZING HORMONE (LH) | 489 | $ - 0 | $ - 0 |
| PROCALCITONIN | 263 | $ - 0 | $ - 0 |
| PROGESTERONE | 138 | $ - 0 | $ - 0 |
| PROLACTIN | 860 | $ - 0 | $ - 0 |
| RAPID/INTACT PARATHYROID HORMONE (PTH) THAT IS INTRAOPERATIVE CAPABLE | 2,041 | $ - 0 | $ - 0 |
| TOTAL TESTOSTERONE | 433 | $ - 0 | $ - 0 |
| TRIIODOTHYRONINE (FREE T3) | 312 | $ - 0 | $ - 0 |
| URINE DRUGS OF ABUSE | $ - 0 | $ - 0 | |
| AMPHETAMINE | 1,028 | $ - 0 | $ - 0 |
| BARBITURATE | 1,028 | $ - 0 | $ - 0 |
| BENZODIAZEPINE | 1,028 | $ - 0 | $ - 0 |
| CANNOBINOID | 1,028 | $ - 0 | $ - 0 |
| COCAINE | 1,028 | $ - 0 | $ - 0 |
| OPIATE | 1,028 | $ - 0 | $ - 0 |
| PHENCYCLIDINE | 1,028 | $ - 0 | $ - 0 |
| IMMUNONOLOGY | |||
| ANTI STREPTOLYSIN O (ASO) | 27 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN A | 262 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN G | 227 | $ - 0 | $ - 0 |
| IMMUNOGLOBULIN M | 227 | $ - 0 | $ - 0 |
| RHEUMATOID FACTOR (RF) | 378 | $ - 0 | $ - 0 |
| THERAPEUTIC DRUGS | |||
| ACETAMINOPHEN | 297 | $ - 0 | $ - 0 |
| CARBAMAZEPINE | 30 | $ - 0 | $ - 0 |
| DIGOXIN | 59 | $ - 0 | $ - 0 |
| GENTAMICIN | 24 | $ - 0 | $ - 0 |
| LITHIUM | 50 | $ - 0 | $ - 0 |
| PHENOBARBITAL | 31 | $ - 0 | $ - 0 |
| PHENYTOIN | 27 | $ - 0 | $ - 0 |
| SALICYLATE | 254 | $ - 0 | $ - 0 |
| TOBRAMYCIN | 21 | $ - 0 | $ - 0 |
| THEOPHYLLINE | 23 | $ - 0 | $ - 0 |
| VALPORIC ACID | 62 | $ - 0 | $ - 0 |
| VANCOMYCIN | 250 | $ - 0 | $ - 0 |
| Tumor Markers | |||
| 3RD GENERATION TOTAL PROSTATE SPECIFIC ANTIGEN (PSA) | 2,576 | $ - 0 | $ - 0 |
| ALPHA FETAL PROTIEN | 212 | $ - 0 | $ - 0 |
| CA-125 ANTIGEN | 95 | $ - 0 | $ - 0 |
| CARCINOEMBRYONIC ANTIGEN (CEA) | 231 | $ - 0 | $ - 0 |
| FREE PROSTATE SPECIFIC ANTIGEN (PSA) | 458 | $ - 0 | $ - 0 |
| URINE CHEMISTRY | |||
| MICROALBUMIN | 8,119 | $ - 0 | $ - 0 |
| URINE TOTAL PROTEIN/ CSF TOTAL PROTEIN | 2,103 | $ - 0 | $ - 0 |
| CARDIAC TESTS | |||
| CREATINE KINASE - MUSCLE BRAIN | 84 | $ - 0 | $ - 0 |
| HIGH SENSITIVEITY TROPONIN I | 4,936 | $ - 0 | $ - 0 |
| HIGH SENSITIVITY C-REACTIVE PROTIEN | 135 | $ - 0 | $ - 0 |
| N TERMINAL-PRO BRAIN NATRIURETIC PEPTIDE | 2,244 | $ - 0 | $ - 0 |
| CLIN 4001 TOTAL | $ - 0 |
File details come from the government source that posted it. Updated .